Back to results
US 2025/0325540 A1Published application
Low dose product and method for treating diarrhea
AssigneesMaregade Rx, LLC, White Sands Pharma LLC
InventorsReed B. Hogan II, Joseph A. Fix
Life of this patent
Estimating the term…
Abstract
A method of treating diarrhea in a patient includes administering a dose of 2.0-7.0 mg of cetirizine and 3.0-15.0 mg of famotidine.
Claims22
A method of treating diarrhea in a patient, comprising:
- administering cetirizine and famotidine, wherein the cetirizine is administered in a dose of 2.0-7.0 mg per day and the famotidine is administered in a dose of 3.0-15.0 mg per day.
A pharmaceutical composition for treating diarrhea, comprising:
- 2.0-7.0 mg cetirizine, and
- 3.0-15.0 mg famotidine.
A method of treating IBS-D in a patient, comprising:
- administering cetirizine and famotidine to the patient, wherein the cetirizine is administered in a dose of 2.0-7.0 mg per day and the famotidine is administered in a dose of 3.0-15.0 mg per day.
Dependencies are inferred from the claim text.